Meta-analysis of Efficacy of Topotecan
NCT01160185 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2010-07-12
Summary
This meta-analysis was conducted to investigate the efficacy of Topotecan and other treatments for recurrent and stage IVB carcinoma of the cervix
Conditions
- Cervical Intraepithelial Neoplasia
Interventions
- DRUG
-
paclitacel
- DRUG
-
cisplatin monotherapy
- DRUG
-
topotecan
topotecan
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 21 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
More Related Trials
-
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
NCT00548418 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix
NCT02492503 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Clinical Study in Post-operation Treatment of Cervical Cancer
NCT01418859 ·Status: UNKNOWN
-
Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
NCT00006482 ·Status: TERMINATED ·Phase: PHASE2
-
Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
NCT00276796 ·Status: COMPLETED ·Phase: PHASE2
-
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
NCT00287911 ·Status: COMPLETED ·Phase: PHASE1
-
Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
NCT00006224 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer
NCT00322920 ·Status: TERMINATED ·Phase: PHASE1
-
Phase II Study of Pazopanib and Topotecan in Cervical Cancer
NCT02348398 ·Status: WITHDRAWN ·Phase: PHASE2
-
Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
NCT00003945 ·Status: COMPLETED ·Phase: PHASE3
-
Belotecan (CKD-602) in Recurrent or Progressive Carcinoma of Uterine Cervix
NCT00430144 ·Status: COMPLETED ·Phase: PHASE2
-
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
NCT00257816 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Cisplatin in Cervical Cancer Stage IVB
NCT00826891 ·Status: UNKNOWN ·Phase: PHASE2
-
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
NCT00803062 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
NCT00054444 ·Status: COMPLETED ·Phase: PHASE1
-
Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer
NCT04395612 ·Status: UNKNOWN ·Phase: PHASE2
-
Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
NCT00030472 ·Status: TERMINATED ·Phase: PHASE2
-
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
NCT00295789 ·Status: COMPLETED ·Phase: PHASE3
-
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
NCT00016926 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT00041093 ·Status: COMPLETED ·Phase: PHASE2
-
Bryostatin-1 Plus Cisplatin in Treating Patients With Recurrent or Advanced Cancer of the Cervix
NCT00005965 ·Status: COMPLETED ·Phase: PHASE2
-
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
NCT00039442 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
NCT00064077 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
NCT05798819 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)
NCT05715840 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3